Skip to main content
. 2022 Jun 22;7(12):e157865. doi: 10.1172/jci.insight.157865

Figure 9. Cytokine and complement biomarker differences between individuals who are CF-NTMNEG and CF-NTMPOS are pronounced in the RUL.

Figure 9

Lobe-specific cytokine and complement concentration data from all individuals in each cohort were analyzed via PCA to identify correlates of CF status and NTM infection history status. PCA scores for the first and second components of cytokine concentrations from the left lung lobes (A) LUL, (B) Ling, and (C) LLL, as well as the right lung lobes (D) RUL, (E) RML, and (F) RLL.